The field of ENT, hearing and balance is being rapidly driven by scientific breakthroughs and growing private and public investments. The next few years will see a significant number of novel therapeutics for ENT, hearing and balance disorders entering the clinical trial phase. These range from small molecule drugs to gene and cell therapies. This emerging field requires sound and validated clinical development methodologies accepted by regulatory authorities.
ENT Clinical is your bespoke CRO in the field of ENT, hearing and balance clinical research.
With a focus on ENT, hearing and balance indications, we bring scientific and clinical knowledge together with operational excellence to the design and conduct of clinical trials for biotech and pharma companies.
During the ARO Midwinter Meeting this month, we conducted a workshop entitled “Translating Pre-Clinical Findings Into Successful Clinical Trials” in collaboration with CILcare.
More info and the replay, click here.
NOV 2020 – In collaboration with CILcare, we presented the webinar:
Key success criteria for hearing (pre)clinical trials.
Detailed information and the replay, click here